The group of Prof. Luca Salassa (Donostia International Physics Center) in collaboration with the groups of Profs. Walter Berger and Bernhard K. Keppler (Research Platform “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna) published a new study on Scientific Reports highlighting the possibility of combining photocatalysis and Pt(IV) prodrugs in the treatment of cancer.
- Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis
Silvia Alonso-de Castro, Alessio Terenzi, Sonja Hager, Bernhard Englinger, Adriana Faraone, Javier Calvo Martínez, Markus Galanski, Bernhard K. Keppler, Walter Berger, Luca Salassa
Scientific Reports, November 2018 - Inorganic Photochemistry Lab, Donosita International Physics Center/UVP-EHU
- Research Cluster Translational Cancer Therapy Research
